- Oops!Something went wrong.Please try again later.
ASML, featured in today's IBD 50 Stocks To Watch, is fast approaching a new buy point as earnings growth accelerates.
Despite sell-offs roiling the broader market, the stock of Digital World Acquisition (NASDAQ: DWAC) is rocketing higher today. There doesn't appear to be any fresh news powering the gains, but excitement surrounding the stock is surging ahead of the company's merger with Trump Media & Technology Group and the launch of their social media platform, Truth Social. It's a social media service backed by Donald Trump that's on track to launch Feb. 21, and investors are pouring into Digital World Acquisition stock ahead of the debut.
Nothing seems to be going right for Novavax (NASDAQ: NVAX) these days. The European Commission granted authorization to Novavax's Nuvaxovid COVID vaccine in December. On Jan. 14, HAS approved Nuvaxovid, making it the fifth COVID-19 vaccine approved in the country.
The IRS has good news for retirees starting in 2022: you can now keep more money in your tax-deferred retirement accounts thanks to lower required minimum distributions (RMDs). For the first time in 20 years, the Internal Revenue Service has … Continue reading → The post Good News for Retirees: RMD Formula Changing for First Time in Decades appeared first on SmartAsset Blog.
Bill Baruch, Blue Line Futures President, and Jason Ware, Albion Financial Group Partner and Chief Investment Officer, join Yahoo Finance Live to discuss market lows, the Fed, the financial and bank sectors, and investing opportunities amid high volatility periods.
Let’s talk about quality stocks. Of course, this is the direction that every investor wants to go; but the question is, how to recognize them? Do we go all-in on the big-value, big-name giants? Or do we dig a little deeper, and find the high-end nuggets that are hiding in the sandheap? Weighing in from investment bank Morgan Stanley, chief investment officer Lisa Shalett recommends the latter. She recommends investors to look for beaten-down stocks, equities that have lost value recently – but t
Chinese President Xi Jinping took to the virtual stage at Davos to address Fed Chair Jerome Powell -- please don't lift interest rates.
What happened Chinese electric vehicle maker Nio (NYSE: NIO) was one of many electric vehicle companies whose shares were trading lower on Tuesday afternoon, amid a broad market decline triggered by rising rates on government bonds.
When interest rates increase, here's what historically has happened to the stock market.
California prosecutors have filed two counts of vehicular manslaughter against the driver of a Tesla on Autopilot who ran a red light, slammed into another car and killed two people in 2019.
Shares of the consumer goods giant dropped as investors digested a failed attempt to buy its way into the healthcare niche.
J.P. Morgan Asset Management Global Market Strategist Jack Manley joins Yahoo Finance Live to discuss stocks selling off, fourth quarter earnings for big banks, inflation data, and the Fed.
Share prices of Rivian Automotive (NASDAQ: RIVN) briefly fell to $75.13 per share on Friday before closing the session at $79.95 per share. It was the first time Rivian stock dipped below its initial public offering (IPO) price of $78 per share. Howard Smith: Markets aren't always efficient, and that's how investors can gain an advantage.
Meme stock trio AMC Entertainment (NYSE: AMC), GameStop (NYSE: GME), and Tonix Pharmaceuticals (NASDAQ: TNXP) were all lower in morning trading Tuesday following the long weekend. There was no news directly associated with any of the stocks, but GameStop has a tangential relationship to big market news -- though it may surprise a few people its shares are moving in the direction they are. Microsoft announced this morning it was acquiring Activision Blizzard for almost $70 billion in cash, or around $95 per share.
Tilray CEO Irwin Simon joins Yahoo Finance Live’s Julie Hyman to discuss the cannabis industry, why the company is pivoting to food and beverage brands, weed legalization in the U.S., and the end of a partnership with Budweiser.
These three top growth names are already down a lot and trade at fair prices, but could become really huge bargains if the market falls more amid rising interest rates.
Shares of clinical-stage biotech companies can skyrocket in a short period based on positive clinical and regulatory news. With that said, let's look at two clinical-stage biotechs that currently boast significant upside potential if we go by average price targets assigned by Wall Street analysts: CRISPR Therapeutics (NASDAQ: CRSP) and Axsome Therapeutics (NASDAQ: AXSM).
(Bloomberg) -- Microsoft Corp. is buying Activision Blizzard Inc. in a $68.7 billion all-cash acquisition, uniting two of the biggest forces in video games. It’s the software maker’s biggest deal ever, almost three times as large as the 2016 purchase of LinkedIn. Here are five key reasons why it happened.Most Read from BloombergMicrosoft Buys Scandal-Tainted Activision in Bet on MetaverseFourth Pfizer Dose Is Insufficient to Ward Off Omicron, Israeli Trial SuggestsStock Selloff Deepens as Treasu
Shares of Romeo Power (NYSE: RMO) are sinking amid a day of sell-offs for the broader market. In addition to bearish pressures impacting the market, Romeo Power stock also seems to be losing ground due to a recently announced change for its management team. Romeo Power's recent press release stated that Anne Devine will take over the COO position roughly a month from today.
(Bloomberg) -- Just over a year ago, Margarita Louis-Dreyfus’s financial outlook looked grim. Most Read from BloombergDeadly Strikes on UAE Upset Efforts to Ease Gulf FrictionsFourth Pfizer Dose Is Insufficient to Ward Off Omicron, Israeli Trial SuggestsOne of the World’s Wealthiest Oil Exporters Is Becoming UnlivableDjokovic Loses Shot at Tennis History as Australia Deports StarChina Cuts Interest Rate as Growth Risks Worsen With OmicronThe Russian-born heiress was trying to sell a stake in Lou
While the industry is full of promising growth stocks, some of which are already achieving recurring profitability, the following four pot stocks, all of which have a Canadian focus, should be avoided like the plague in 2022. The award for the most times a pot stock has appeared on a "stocks to avoid list" unquestionably goes to Canadian licensed producer Aurora Cannabis (NASDAQ: ACB). Once upon a time, Aurora was the premier name among Canadian weed stocks.